Comparison of prostatic and nonprostatic acid phosphatase
- PMID: 6953921
- DOI: 10.1111/j.1749-6632.1982.tb40300.x
Comparison of prostatic and nonprostatic acid phosphatase
Abstract
Electrophoresis and ion-exchange column chromatography were used to separate the wide varieties of acid phosphatases with different biological and clinical significance. Band 0 was very strong in ascitic cells with many autophagic vacuoles, indicating a role in autophagic function. Band 1 was a membrane-bound acid phosphatase, seen mainly in the microsomal fraction. Band 3 was the major lysosomal acid phosphatase of all nonprostatic tissues. Bands 2 and 4 were antigenically identical to each other, and were observed in unusually high amounts in the prostate. The different electrophoretic mobility between bands 2 and 4 was due to their carbohydrate content. Band 5 was a characteristic enzyme of the osteoclast. The tartrate-sensitive enzymes included bands 0 through 4. Only band 5 was tartrate resistant. The tartrate-resistant acid phosphatase of erythrocytes was not detected by the electrophoresis method. Clinical applications were seen for both bands 2 and 5. Band 2 was a secretory enzyme, normally secreted into the seminal plasma. Band 2 was absorbed into the blood circulation in some prostatic cancer patients. A small amount of bands 2 and 4 was observed in nonprostatic tissues. The diagnostic value of band 2 resulted from its extremely high concentration in the prostate. Band 5 was not observed in the normal prostate. A high concentration of band 5 was observed in hairy cells, Gaucher cells, and osteoclasts. The serum level of band 5b was an indicator of osteoclastic activity in the bone. Elevation of band 5b in serum was observed in normal children during physiological bone growth, in Gaucher's disease, and in malignancies metastasized to bone.
Similar articles
-
Acid phosphatases.Mol Pathol. 2002 Apr;55(2):65-72. doi: 10.1136/mp.55.2.65. Mol Pathol. 2002. PMID: 11950951 Free PMC article. Review.
-
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.J Clin Endocrinol Metab. 1990 Aug;71(2):442-51. doi: 10.1210/jcem-71-2-442. J Clin Endocrinol Metab. 1990. PMID: 2380339
-
Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.Clin Biochem. 1981 Aug;14(4):177-81. doi: 10.1016/s0009-9120(81)91201-7. Clin Biochem. 1981. PMID: 6794944
-
[Acid phosphatase, ACP (EC 3.1.3.2)].Rinsho Byori. 2001 Nov;Suppl 116:100-9. Rinsho Byori. 2001. PMID: 11797369 Review. Japanese.
-
Elevation of serum acid phosphatase in cancers with bone metastasis.Cancer. 1980 May 1;45(9):2400-3. doi: 10.1002/1097-0142(19800501)45:9<2400::aid-cncr2820450927>3.0.co;2-n. Cancer. 1980. PMID: 7379037
Cited by
-
Immunological characterization of human acid phosphatase gene products.Biochem Genet. 1985 Apr;23(3-4):309-19. doi: 10.1007/BF00504327. Biochem Genet. 1985. PMID: 4015620
-
Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups.Korean J Pediatr. 2012 Feb;55(2):48-53. doi: 10.3345/kjp.2012.55.2.48. Epub 2012 Feb 14. Korean J Pediatr. 2012. PMID: 22375149 Free PMC article.
-
Kinetic Studies of Newly Patented Aminoalkanol Derivatives with Potential Anticancer Activity as Competitive Inhibitors of Prostate Acid Phosphatase.Int J Mol Sci. 2021 Oct 29;22(21):11761. doi: 10.3390/ijms222111761. Int J Mol Sci. 2021. PMID: 34769193 Free PMC article.
-
Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines.Mol Cell Biol. 1986 Dec;6(12):4753-7. doi: 10.1128/mcb.6.12.4753-4757.1986. Mol Cell Biol. 1986. PMID: 3796616 Free PMC article.
-
Acid phosphatases.Mol Pathol. 2002 Apr;55(2):65-72. doi: 10.1136/mp.55.2.65. Mol Pathol. 2002. PMID: 11950951 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources